Products

ata-validator

A JSON Schema validator that runs where code generation is blocked

ata-validator.com Source★ 49MITSoftware Development / Developer Utilities

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Launched
45d ago
2026-10-06 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Fast, correct JSON Schema validation for JavaScript

    Oct 6 · 45d agoLaunch page

    At the time: <5K visits/mo

Open Source & Agent Ecosystem

GitHub · MCP / Skill
Last commit 2026-11-01
GitHub Stars
★ 49
Forks
—
License
MIT
Primary language
JavaScript

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-03-22

KeywordMonthly volume
npm har validator280

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-06 · Source page

Website snapshots

Indexed 2026-10-06

Key pages

Desktop & mobile archive
ata-validator.com/ Snapshot 2026-11-06

Questions & evidence

How much website traffic does ata-validator get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ata-validator and what platforms does it support?
ata-validator is catalogued under Developer Utilities: A JSON Schema validator that runs where code generation is blocked. Supported platforms: CLI / SDK.
Is ata-validator open source?
ata-validator has a public repository (https://github.com/ata-core/ata-validator) under the MIT license, recording 49 GitHub stars.Source

Related products in this category

Software Development / Developer Utilities

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.